RLBFX
Price
$40.98
Change
+$0.34 (+0.84%)
Updated
Jun 18 closing price
Net Assets
287.61B
SQCBX
Price
$15.44
Change
+$0.10 (+0.65%)
Updated
Jun 18 closing price
Net Assets
102.8M
Interact to see
Advertisement

RLBFX vs SQCBX

RLBFX vs SQCBX Comparison Chart in %
View a ticker or compare two or three
VS
RLBFX vs. SQCBX commentary
Jun 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBFX is a Hold and SQCBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 288B vs. SQCBX (103M). RLBFX pays higher dividends than SQCBX: RLBFX (2.02) vs SQCBX (1.73). RLBFX was incepted earlier than SQCBX: RLBFX (24 years) vs SQCBX (7 years). SQCBX (2.64) is less costly to investors than RLBFX (0.30). RLBFX is a more actively managed with annual turnover of: 50.00 vs. SQCBX (9.70). RLBFX has a lower initial minimum investment than SQCBX: RLBFX (250) vs SQCBX (5000). SQCBX annual gain was more profitable for investors over the last year : 18.60 vs. RLBFX (16.27). SQCBX (39.52) and RLBFX (38.33) have equivalent 5 years return.
RLBFXSQCBXRLBFX / SQCBX
Total Expense Ratio0.302.6411%
Annual Report Gross Expense Ratio0.302.6411%
Fund Existence24 years7 years-
Gain YTD8.9738.982100%
Front LoadN/AN/A-
Min. Initial Investment25050005%
Min. Initial Investment IRAN/AN/A-
Net Assets288B103M279,612%
Annual Yield % from dividends2.021.73116%
Returns for 1 year16.2718.6087%
Returns for 3 years43.4845.6995%
Returns for 5 years38.3339.5297%
Returns for 10 years91.15N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFWGX18.01-0.18
-0.99%
MFS Global Total Return R1
ADRRX20.27-0.30
-1.46%
American Century Disciplined Growth R
NCEGX23.82-0.38
-1.57%
The North Country Large Cap Equity Fund
RRBGX186.88-2.98
-1.57%
T. Rowe Price Blue Chip Growth R
SMVLX92.72-1.66
-1.76%
Smead Value Investor